がんバイオマーカー:個別化治療の新興傾向と臨床的影響

Antonio Passaro¹, Maise Al Bakir², Emily G Hamilton³

¹Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy.

Cell

|March 29, 2024

まとめ

癌のバイオマーカーが腫瘍学とパーソナライズド医療に革命を起こしていますこのレビューは,固体腫瘍の管理と患者のアウトカムを改善するための重要なマイルストーンと将来の方向性をカバーしています.

科学分野:

腫瘍学
バイオマーカーの発見
パーソナライズされた医療

背景:

癌のバイオマーカーは癌の治療と患者の予後を変えました
パーソナライズされた医療は腫瘍の分子のプロフィールによって導かれますがん管理の新たなパラダイムです

研究の目的:

癌のバイオマーカーの開発における科学的マイルストーンをレビューする.
固体腫瘍の管理におけるバイオマーカーの将来の応用を探求する.

主な方法:

癌のバイオマーカーに関する科学文献のレビュー
癌生物学,検査方法論,腫瘍プロファイルの進歩の分析

主要な成果:

バイオマーカーの統合は癌の治療において大きな進歩をもたらしました
癌の生物学や免疫の微小環境や腫瘍のDNAの循環によって進歩が進んでいます

結論:

バイオマーカーのインサイトを継続的に統合することで精密腫瘍学が進歩します
強化されたバイオマーカー戦略は固体腫瘍の治療における患者の改善を約束しています

さらに関連する動画

07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.7K

関連する概念動画

02:50

Combination Therapies and Personalized Medicine

4.9K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

4.9K

01:21

Cancer Survival Analysis

345

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

345

01:30

Cancer Vaccines

363

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

363

01:27

Tumor Immunotherapy

523

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

523

02:18

Cancer

48.5K

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

48.5K

02:56

Treatment Resistant Cancers

3.3K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...